Zimmer Biomet's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 4 ...

Zimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...

Zimmer Biomet’s flagship robot, Rosa, is expected to make gains in the near future, CEO Ivan Tornos said at the Barclays 27th Annual Global Healthcare Conference. Mr. Tornos said adoption of the robot ...

Zimmer Biomet CEO Ivan Tornos said he anticipates ASCs to be a major support for growing orthopedic case volumes during the Barclays 27th Annual Global Healthcare Conference. “That is a huge tailwind ...

In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).

This was the stock's second consecutive day of losses.

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

The stock's fall snapped a four-day winning streak.

The Terminator actor teamed up with Zimmer Biomet to raise awareness about osteoarthritis, which affects more than 25 million ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...

Zimmer Biomet CPT ® Hip System implants may put patients at an increased risk of suffering a broken thigh bone near the device. In some cases, patients may even need to undergo corrective surgery. At ...

WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71.6%, ...